Bottom line
SBHIX vs HTEC: the short answer
SBHIX (Health & Biotechnology Portfolio) and HTEC (ROBO Global(R) Healthcare Technology and Innovation ETF) are both mutual funds.
But HTEC is far broader, holding 63 positions to 29 for SBHIX, so beyond the top names it adds exposure SBHIX doesn't have.
HTEC is cheaper at 0.68% vs 2.6% — a difference of $192 a year per $10,000 invested.
Over five years, SBHIX returned +4.7% a year vs −3.9% for HTEC (reporting dates differ).
Updated Nov 19, 2026
SBHIX vs HTEC side by side
| SBHIX | HTEC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Saratoga Advantage | Innovator |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 2.6% | 0.68% |
| Annual cost per $10k | $260 | $68 |
| 10-yr cost on $10k (prospectus) | $2,934 | $979 |
| Max front load | 0% | None |
| 12b-1 fee | — | 0% |
| 1-yr return | +0.7% | +24.0% |
| 5-yr return (annualized) | +4.7% | −3.9% |
| 10-yr return (annualized) | +5.2% | — |
| Best quarter | +15.0% | +30.7% |
| Worst quarter | −13.0% | −20.8% |
| Net assets (fund) | $10.5M | $69.1M |
| Number of holdings | 29 | 63 |
| Portfolio turnover | 22% | 38% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | SBHIX | HTEC | Difference |
|---|---|---|---|
| 2024 | +0.7% | +2.8% | −2.1% |
| 2023 | +0.0% | −3.0% | +3.1% |
| 2022 | +2.4% | −33.6% | +36.0% |
| 2021 | +17.2% | −0.2% | +17.4% |
| 2020 | +4.0% | +65.2% | −61.2% |
Source: Fund prospectus bar charts
Holdings overlap
5 of SBHIX's top 25 holdings also appear in HTEC's top 25.
| Holding | SBHIX | HTEC |
|---|---|---|
| Regeneron Pharmaceuticals Inc | 3.93% | 1.97% |
| Medpace Holdings Inc | 3.37% | 2.12% |
| Vertex Pharmaceuticals Inc | 3.36% | 1.91% |
| Incyte Corp | 2.89% | 1.80% |
| Stryker Corp | 2.40% | 1.91% |
Source: SEC Form N-PORT
SBHIX top 10
- Cardinal Health Inc — 6.44%
- Jazz Pharmaceuticals Plc — 6.19%
- United Therapeutics Corp — 6.17%
- Amgen Inc — 5.04%
- Mckesson Corp — 4.90%
- Lantheus Holdings Inc — 4.64%
- Exelixis Inc — 4.55%
- Novartis Ag — 4.50%
- Cencora Inc — 4.33%
- Gilead Sciences Inc — 3.94%
HTEC top 10
- Caredx, Inc. — 2.68%
- Guardant Health, Inc. — 2.31%
- Natera, Inc. — 2.23%
- Twist Bioscience Corp — 2.23%
- Thermo Fisher Scientific Incorporated — 2.18%
- Medpace Holdings, Inc. — 2.12%
- Adaptive Biotechnologies Corporation — 2.11%
- Iqvia Holdings Inc — 2.10%
- Illumina, Inc. — 2.09%
- Arrowhead Pharmaceuticals, Inc. — 2.08%
FAQ
What is the difference between SBHIX and HTEC?
Which is cheaper, SBHIX or HTEC?
Should I own both SBHIX and HTEC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.